Harvey RD, Rubinstein WS, Ison G, et al. Impact of broadening clinical trial eligibility criteria for advanced non-small cell lung cancer patients: Real-world analysis. ASCO Annual Meeting 2019, abstract LBA108.
CDK4/6-remmers bij gemetastaseerd HR+, HER2- mammacarcinoom
mei 2019 | Borstkanker